The Role of Surfactants in the Reversal of Active Transport Mediated by Multidrug Resistance Proteins
Overview
Pharmacy
Affiliations
A variety of seven nonionic, one amphoteric and, one anionic surfactant that are applied or investigated as surfactants in drug formulation, were analyzed for their capacity to modulate carrier-mediated transport by efflux pumps. Two cell lines, murine monocytic leukemia cells overexpressing P-glycoprotein (P-gp) and Madin-Darby canine kidney cells stably overexpresssing human multidrug resistance-associated protein 2 (MRP2), were used as test systems. The modulation of P-gp and of MRP2 function was studied by the reversal of rhodamine 123 and of methylfluorescein-glutathione conjugate transport, respectively. Mechanisms that were not transporter related and could lead to misinterpretations were identified, such as probe quenching, probe encapsulation by micelles, and membrane damage. P-gp-mediated rhodamine 123 transport was inhibited by five nonionic surfactants in a concentration-dependent manner and in the order TPGS > Pluronic PE8100 > Cremophor EL > Pluronic PE6100 approximately Tween 80. In contrast, none of the surfactants showed a significant inhibition of MRP2-mediated efflux in Madin-Darby canine kidney/MRP2 cells. In conclusion, the results indicate that surfactants demonstrate a transporter-specific interaction, rather than unspecific membrane permeabilization. The present analysis offers insight in the possible mechanisms of surfactant interactions with biological membranes and could help to identify specific drug formulations.
Ali R, Qamar W, Kalam M, Binkhathlan Z ACS Omega. 2024; 9(40):41830-41840.
PMID: 39398132 PMC: 11465523. DOI: 10.1021/acsomega.4c06264.
Pires C, Moreno M Membranes (Basel). 2024; 14(7).
PMID: 39057665 PMC: 11278619. DOI: 10.3390/membranes14070157.
Kondiah P, Rantso T, Makhathini S, Mdanda S, Choonara Y Biomedicines. 2022; 10(7).
PMID: 35884775 PMC: 9313284. DOI: 10.3390/biomedicines10071470.
The Emerging Role of Ultrasonic Nanotechnology for Diagnosing and Treatment of Diseases.
Liu X, Ge W Front Med (Lausanne). 2022; 9:814986.
PMID: 35273976 PMC: 8901503. DOI: 10.3389/fmed.2022.814986.
Rathod S, Desai H, Patil R, Sarolia J AAPS PharmSciTech. 2022; 23(1):55.
PMID: 35043278 DOI: 10.1208/s12249-022-02211-1.